Cargando…

The economic impact of compassionate use of medicines

BACKGROUND: Compassionate use programs (CUP) for medicines respond to the ethical imperative of providing access to medicines before marketing approval to patients not recruited in trials. The economic impact of clinical trials has previously been investigated. No evidence on the net economic benefi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jommi, Claudio, Pantellini, Federico, Stagi, Lisa, Verykiou, Maria, Cavazza, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645125/ https://www.ncbi.nlm.nih.gov/pubmed/34863155 http://dx.doi.org/10.1186/s12913-021-07255-w

Ejemplares similares

Health care costs of influenza-related episodes in high income countries: A systematic review
por: Federici, Carlo, et al.
Publicado: (2018)

The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
por: Otto, Monica Hildegard, et al.
Publicado: (2018)

Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
por: Otto, Monica Hildegard, et al.
Publicado: (2019)

Compassionate use of orphan drugs
por: Hyry, Hanna I., et al.
Publicado: (2015)

Compassionate use of cell products
por: de Santis, Gil Cunha, et al.
Publicado: (2013)

Measuring compassionate healthcare with the 12-item Schwartz Center Compassionate Care Scale
por: Rodriguez, Ana Maria, et al.
Publicado: (2019)

Letermovir for the compassionate therapeutic use of cytomegalovirus infection
por: Schubert, Lorenz, et al.
Publicado: (2020)

Compassionate Health Care
por: Malliarou, Maria
Publicado: (2022)

Ethics review in compassionate use
por: Borysowski, Jan, et al.
Publicado: (2017)

COVID: Its compassionate use
por: Bennett, Jasmiry
Publicado: (2020)

Compassionate Care
por: Post, Stephen G., et al.
Publicado: (2012)

Compassionate Conversations
por: Gardner, Sharryn, et al.
Publicado: (2014)

Compassionate Counterterrorism
por: Olaimy, Leena
Publicado: (2019)

Implementation Models of Compassionate Communities and Compassionate Cities at the End of Life: A Systematic Review
por: Librada-Flores, Silvia, et al.
Publicado: (2020)

Correction: Measuring compassionate healthcare with the 12-item Schwartz Center Compassionate Care Scale
por: Rodriguez, Ana Maria, et al.
Publicado: (2019)

Compassionate Leadership: Essential for the Future of Tropical Medicine and Global Health
por: Harrel, Evan, et al.
Publicado: (2021)

Building Compassionate Experience Through Compassionate Action: Qualitative Behavioral Analysis
por: Desveaux, Laura, et al.
Publicado: (2023)

Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID‐19
por: Aliu, Paul, et al.
Publicado: (2020)

The teachings of the compassionate Buddha
Publicado: (1955)

Compassionate ethics for clinics
por: Kim, Tae-Il
Publicado: (2013)

The Compassionate and Forgiving Organization
por: Lennick, Doug
Publicado: (2010)

Compassionate use of remdesivir in children with COVID-19
por: Méndez-Echevarría, Ana, et al.
Publicado: (2020)

Compassionate Use of Yuanjiang Decoction, a Traditional Chinese Medicinal Prescription, for Symptomatic Bradyarrhythmia
por: Wan-Tong, Zhang, et al.
Publicado: (2022)

Interdependent = Compassionate? Compassionate and Self-Image Goals and Their Relationships With Interdependence in the United States and Japan
por: Niiya, Yu, et al.
Publicado: (2019)

The measurement of compassionate leadership: Adaptation and Spanish validation of the compassionate leadership self‐reported scale
por: Sansó, Noemí, et al.
Publicado: (2022)

Structural violence and the need for compassionate use of methadone in Mexico
por: Romero-Mendoza, Martha, et al.
Publicado: (2022)

Compassionate use programs in Italy: ethical guidelines
por: De Panfilis, Ludovica, et al.
Publicado: (2018)

Compassionate drug use: Current status in India
por: Shetty, Yashashri C., et al.
Publicado: (2020)

Kindling Kindness for Compassionate Disaster Management
por: Johal, Sarb
Publicado: (2015)

Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system
por: Galeone, Carlotta, et al.
Publicado: (2021)

A doctor’s compassionate touch
por: Miao, Julia H, et al.
Publicado: (2021)

Providing Compassionate Care in the ICU
por: Curtis, J. Randall, et al.
Publicado: (2022)

COVID-19 and the reimaging of compassionate release
por: James, Jennifer E., et al.
Publicado: (2022)

How do we sustain compassionate healthcare? Compassionate leadership in the time of the COVID-19 pandemic
por: de Zulueta, Paquita
Publicado: (2021)

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections
por: Meschiari, Marianna, et al.
Publicado: (2021)

Characterizing expanded access and compassionate use programs for experimental drugs
por: Miller, Jennifer E., et al.
Publicado: (2017)

Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs
por: Puthumana, Jeremy, et al.
Publicado: (2018)

Compassionate use programmes for rare diseases: proposals for actions
por: Houÿez, François, et al.
Publicado: (2012)

Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
por: Eibenschutz, Laura, et al.
Publicado: (2013)

Compassionate use of experimental therapies: who should decide?
por: Zettler, Patricia J
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4j67utjkl3qc7rmtns22nrn7fg